BRAIN Biotech AG
BRAIN Biotech AG, a leading player in the biotechnology sector, is headquartered in Germany and operates extensively across Europe. Founded in 1997, the company has established itself as a pioneer in the development of innovative bioprocesses and products, particularly in the fields of industrial enzymes and biobased materials. BRAIN Biotech AG offers a unique portfolio of services, including enzyme development and microbial strain optimisation, which cater to various industries such as agriculture, food, and pharmaceuticals. The company is recognised for its commitment to sustainability and efficiency, positioning itself as a key contributor to the circular economy. With a strong market presence and notable achievements in biotechnological advancements, BRAIN Biotech AG continues to drive innovation, making significant strides in enhancing productivity and environmental sustainability across multiple sectors.
DitchCarbon Score
How does BRAIN Biotech AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
BRAIN Biotech AG's score of 5 is lower than 74% of the industry. This can give you a sense of how well the company is doing compared to its peers.
BRAIN Biotech AG's reported carbon emissions
In 2022, BRAIN Biotech AG reported total carbon emissions of approximately 1,379,890 kg CO2e, with emissions from Scope 1 and Scope 2 each contributing the same amount. This marked a significant increase from 2020, when total emissions were about 1,515,656 kg CO2e, with Scope 1 and Scope 2 emissions also equal at approximately 971,790 kg CO2e each. Despite the lack of specific reduction targets or initiatives disclosed, BRAIN Biotech AG is committed to addressing its carbon footprint. The company has not outlined any science-based targets or climate pledges, indicating a potential area for future development in their sustainability strategy. As the biotech industry increasingly focuses on climate commitments, BRAIN Biotech AG's emissions data highlights the need for enhanced efforts in reducing greenhouse gas emissions.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2020 | 2022 | |
|---|---|---|
| Scope 1 | 971,790 | 0,000,000 |
| Scope 2 | 971,790 | 0,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
BRAIN Biotech AG is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
